SYNGENE SYNVENT

Serial Number 90065058
Registration 6695032
700

Registration Progress

Application Filed
Jul 21, 2020
Under Examination
Jul 27, 2021
Approved for Publication
Jun 1, 2021
Published for Opposition
Jun 1, 2021
Registered
Apr 5, 2022

Trademark Image

SYNGENE SYNVENT

Basic Information

Serial Number
90065058
Registration Number
6695032
Filing Date
July 21, 2020
Registration Date
April 5, 2022
Published for Opposition
June 1, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 5, 2022
Registration
Registered
Classes
042 044

Rights Holder

Syngene International Limited

99
Address
Biocon SEZ, Biocon Park, Plot # 2 & 3,
Bangalore 560099
Karnataka 560099
IN

Ownership History

Syngene International Limited

Original Applicant
99
Karnataka IN

Syngene International Limited

Owner at Publication
99
Karnataka IN

Syngene International Limited

Original Registrant
99
Karnataka IN

Legal Representation

Attorney
Mark A. Watkins

USPTO Deadlines

Next Deadline
981 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-04-05)
Due Date
April 05, 2028
Grace Period Ends
October 05, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Apr 5, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 4, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Mar 3, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 15, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 14, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 27, 2022 IUAF S USE AMENDMENT FILED Loading...
Jan 27, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jul 27, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jun 1, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 1, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 12, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 29, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 29, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 29, 2021 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Apr 29, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 29, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 9, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 9, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 9, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 4, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 19, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 18, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 29, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 29, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 29, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 24, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific research and custom synthesis; scientific and clinical research in the field of medicine, pharmaceutical, nutraceuticals; scientific research and development; custom design and development of chemical reagents and biochemical assays; laboratory testing services for research purposes; testing of pharmaceuticals; chemical engineering; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; scientific study and research in the field of reproduction, husbandry, and general health of animal; biotechnology research for determining the neuronal survival of molecules in animal models; research and development services in the field of antibodies, antibody technology; custom design and development of chemical reagents and biochemical assays; design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; toxicology services; toxicity analysis; toxicity testing for research purposes; conducting clinical trials for scientific research for others; conducting clinical trials for others in the field of pharmaceutical products; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; blood analysis services for scientific research purposes; analysis of human tissues for medical research; scientific services relating to the isolation and cultivation of human tissues and cells for research purposes; preparation of reports relating to scientific and technical research; analysis in the field of molecular biology; contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific and medical laboratory services; services of a chemical and/or biological laboratory; laboratory research services relating to pharmaceuticals; research and development and consultation related thereto in the field of antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymer, peptide synthesis, protein, and solid state characterization; toxicokinetic analysis and toxicology services; scientific and technological services, namely, scientific research, development, analysis, testing, engineering, extraction, synthesis, purification and production in the field of antibodies, active pharmaceutical ingredients (API), biomolecules, cell bank characterization, chirality, chromosome aberration, clinical chemistry, cloning vector, cyclotides, DNA, flow cytometry, gas chromatography mass spectrometry, genes, immuno-pharmaceuticals, in vitro irritation, large molecule, liquid chromatography mass spectrometry, microbials, monomers, nanoparticles, natural products, peptides, proteins, RNA, supercritical fluid chromatography, small molecules and vaccines; none of the aforesaid services relating to gel imaging and gel analysis applications and none of the aforesaid services in the field of agriculture, horticulture and forestry
First Use Anywhere: Aug 11, 2021
First Use in Commerce: Aug 11, 2021
Class 044
Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes
First Use Anywhere: Aug 11, 2021
First Use in Commerce: Aug 11, 2021

Additional Information

Design Mark
The mark consists of the word "SYNGENE", in a smaller font, above the right half of the word "SYNVENT", the word "SYNVENT" having the the outline of the letter "V" within a solid circle.

Classification

International Classes
042 044